A global AMR surveillance data sharing platform
Dedicated to helping industry share antimicrobial resistance surveillance data with researchers in the fight against AMR

Awardees Announced for the Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome

Vivli is pleased to announce the awardees of the Vivli Antimicrobial Resistance (AMR) Surveillance Open Data Re-Use Data Challenge. A total of 56 teams from 28 different countries participated in the AMR Data Challenge. This event served as a unique platform for multidisciplinary teams to leverage high-quality industry AMR surveillance data, proposing groundbreaking advancements and tools for use in AMR surveillance. The Challenge culminated in the recognition of six outstanding winners for the AMR Surveillance Open Data Re-Use Data Challenge.

VIEW FINALIST AND AWARD-WINNING SOLUTIONS

Why We Support the AMR Register
quote image
“Drug-resistant infections presents one of the biggest threats to our future global health and economic security. Successfully addressing the rise in drug-resistant infections hinges on obtaining and using reliable and openly accessible surveillance data."
quote image
"Industry, patients and healthcare workers can all benefit from this which is why I encourage all industry to contribute to the register. I hope that we can all play our parts to support the Vivli platform in any way we can."
Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance
quote image
“One of things that we have learned is the importance of sharing data and open data, now COVID has shown that it is do-able and that sharing data actually achieves real results."
Dr. Tim Jinks, Head of Infectious Diseases Interventions, Wellcome Trust

 

AMR Register 2023 Progress Report

 

VIEW REPORT

Updates & Events

AMR Register Progress Report Published
» More
Awardees Announced for the Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome
» More
Breaking News– Vivli announces the AMR Surveillance Open Data Re-use Challenge, funded by Wellcome, to Initiate April 19th
» More